Drug intelligence / Profile preview

essential amino acids-University of Oregon

Development stage
Phase 4
Lead developer
University of Oregon
Modality
Small Molecules
Administration
Oral
01

Overview

This essential amino acid (EAA) supplement was developed and studied by researchers at the University of Oregon to prevent muscle atrophy in older adults undergoing total knee arthroplasty (TKA). The formulation is a specific mixture of eight essential amino acids: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, and valine. It acts by stimulating muscle protein synthesis and attenuating muscle protein breakdown, primarily targeting skeletal muscle tissue to counteract the significant quadriceps and hamstrings atrophy typically associated with knee replacement surgery. Clinical trials (NCT02145949 and NCT00760383) have demonstrated that a twice-daily 20-23 gram oral dose, initiated one week prior to surgery and continued for several weeks post-operatively, significantly improves functional mobility and mitigates muscle loss in patients aged 50-80.

Other names
EAAEssential Amino AcidsEAA Supplementation for Atrophy Prevention in TKA
02

Targets

Mechanistic target of rapamycin complex 1

Beyond the preview

Go deeper on essential amino acids-University of Oregon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on essential amino acids-University of Oregon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call